drugset / Trial / NCT06203236

Natriuresis-Guided Diuretic Therapy in Patients With Acute Heart Failure With Reduced Ejection Fraction and Chronic Kidney Disease

NCT06203236

Phase 4 Unknown 300 enrolled Assiut University
RandomizedParallel-groupDouble-blindTreatment

Summary

To investigate the effectiveness and feasibility of natriuresis-guided diuretic therapy as a personalized approach to managing acute heart failure in patients with underlying chronic kidney disease and its effect on short term outcomes.

Timeline

Start
2024-01
Primary completion
2025-03
Completion
2025-11

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Furosemide Other / unclassified 20 mg Intravenous